Aprogen Biologics Inc
KRX:003060
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Aprogen Biologics Inc
Operating Expenses
Aprogen Biologics Inc
Operating Expenses Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
A
|
Aprogen Biologics Inc
KRX:003060
|
Operating Expenses
-₩31.8B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-7%
|
|
|
Yuhan Corp
KRX:000100
|
Operating Expenses
-₩625.5B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-9%
|
|
|
SK Biopharmaceuticals Co Ltd
KRX:326030
|
Operating Expenses
-₩459.9B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
N/A
|
|
|
Hanmi Pharm Co Ltd
KRX:128940
|
Operating Expenses
-₩626.6B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
1%
|
|
|
S
|
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
|
Operating Expenses
-₩100.9B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-7%
|
|
|
C
|
Caregen Co Ltd
KOSDAQ:214370
|
Operating Expenses
-₩31.8B
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
N/A
|
|
Aprogen Biologics Inc
Glance View
Aprogen Biologics, Inc. engages in the manufacture and sale of pharmaceutical products. The company is headquartered in Seoul, Seoul. The firm operates its business through two segments. The Medicine Business segment is engaged in the manufacture and sale of central nervous system drugs, autonomic agents, arteriosclerosis agents, metabolic agents, circulatory system drugs, biopharmaceuticals and others. The Segment is also engaged in the manufacture and sale of cosmetics such as skin moisturizers and others. The Gaming Business segment is engaged in the development and operation of role-playing games (RPGs).
See Also
What is Aprogen Biologics Inc's Operating Expenses?
Operating Expenses
-31.8B
KRW
Based on the financial report for Sep 30, 2025, Aprogen Biologics Inc's Operating Expenses amounts to -31.8B KRW.
What is Aprogen Biologics Inc's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
-7%
Over the last year, the Operating Expenses growth was 38%. The average annual Operating Expenses growth rates for Aprogen Biologics Inc have been -1% over the past three years , -4% over the past five years , and -7% over the past ten years .
